Directorate Change

Sinclair Pharma PLC ("Sinclair" or "the Company")

Announcement

10 June 2011, Sinclair Pharma PLC (SPH:LN), the international specialty pharma company, announces the departure of CFO Matthew Hall from the Company with immediate effect.

Matthew worked at IS Pharma plc ("IS Pharma") alongside CEO Tim Wright from early 2007, initially as financial adviser and then from January 2009 as CFO. He contributed significantly to establishing IS Pharma as a profitable and cash generative specialty pharmaceutical business quoted on the AIM market. At IS Pharma, Matthew led several financing rounds and deal negotiations, and helped transition the business to predominantly institutional ownership. He was instrumental in negotiating the merger with Sinclair by which time the market capitalisation of IS Pharma had been increased to some £45m. Concurrent with the merger he initiated and led the negotiation of a £16m debt facility from Clydesdale Bank on behalf of the enlarged group. Matthew's dedication and hard work before and during the merger has been much appreciated, and he leaves Sinclair IS Pharma with the very best wishes of the Board and our staff.

For further information, please contact: